Literature DB >> 12479928

LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites.

C M Venkatachalam1, X Jiang, T Oldfield, M Waldman.   

Abstract

We present a new shape-based method, LigandFit, for accurately docking ligands into protein active sites. The method employs a cavity detection algorithm for detecting invaginations in the protein as candidate active site regions. A shape comparison filter is combined with a Monte Carlo conformational search for generating ligand poses consistent with the active site shape. Candidate poses are minimized in the context of the active site using a grid-based method for evaluating protein-ligand interaction energies. Errors arising from grid interpolation are dramatically reduced using a new non-linear interpolation scheme. Results are presented for 19 diverse protein-ligand complexes. The method appears quite promising, reproducing the X-ray structure ligand pose within an RMS of 2A in 14 out of the 19 complexes. A high-throughput screening study applied to the thymidine kinase receptor is also presented in which LigandFit, when combined with LigScore, an internally developed scoring function, yields very good hit rates for a ligand pool seeded with known actives.

Mesh:

Substances:

Year:  2003        PMID: 12479928     DOI: 10.1016/s1093-3263(02)00164-x

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  199 in total

1.  Identification of protein biochemical functions by similarity search using the molecular surface database eF-site.

Authors:  Kengo Kinoshita; Haruki Nakamura
Journal:  Protein Sci       Date:  2003-08       Impact factor: 6.725

2.  Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors.

Authors:  Rand Shahin; Saja Alqtaishat; Mutasem O Taha
Journal:  J Comput Aided Mol Des       Date:  2011-12-14       Impact factor: 3.686

3.  Targeting the voltage sensor of Kv7.2 voltage-gated K+ channels with a new gating-modifier.

Authors:  Asher Peretz; Liat Pell; Yana Gofman; Yoni Haitin; Liora Shamgar; Eti Patrich; Polina Kornilov; Orit Gourgy-Hacohen; Nir Ben-Tal; Bernard Attali
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

Review 4.  Structure-based discovery of antibacterial drugs.

Authors:  Katie J Simmons; Ian Chopra; Colin W G Fishwick
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

5.  pK(a) based protonation states and microspecies for protein-ligand docking.

Authors:  Tim ten Brink; Thomas E Exner
Journal:  J Comput Aided Mol Des       Date:  2010-09-30       Impact factor: 3.686

6.  Structural Asymmetry of Phosphodiesterase-9A and a Unique Pocket for Selective Binding of a Potent Enantiomeric Inhibitor.

Authors:  Manna Huang; Yongxian Shao; Jianying Hou; Wenjun Cui; Beibei Liang; Yingchun Huang; Zhe Li; Yinuo Wu; Xinhai Zhu; Peiqing Liu; Yiqian Wan; Hengming Ke; Hai-Bin Luo
Journal:  Mol Pharmacol       Date:  2015-08-27       Impact factor: 4.436

7.  Fragment based discovery of arginine isosteres through REPLACE: towards non-ATP competitive CDK inhibitors.

Authors:  Padmavathy Nandha Premnath; Shu Liu; Tracy Perkins; Jennifer Abbott; Erin Anderson; Campbell McInnes
Journal:  Bioorg Med Chem       Date:  2013-11-07       Impact factor: 3.641

Review 8.  A review of mathematical representations of biomolecular data.

Authors:  Duc Duy Nguyen; Zixuan Cang; Guo-Wei Wei
Journal:  Phys Chem Chem Phys       Date:  2020-02-26       Impact factor: 3.676

9.  Absolute Binding Free Energies between T4 Lysozyme and 141 Small Molecules: Calculations Based on Multiple Rigid Receptor Configurations.

Authors:  Bing Xie; Trung Hai Nguyen; David D L Minh
Journal:  J Chem Theory Comput       Date:  2017-05-01       Impact factor: 6.006

10.  Benchmarking methods and data sets for ligand enrichment assessment in virtual screening.

Authors:  Jie Xia; Ermias Lemma Tilahun; Terry-Elinor Reid; Liangren Zhang; Xiang Simon Wang
Journal:  Methods       Date:  2014-12-03       Impact factor: 3.608

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.